| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780811 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
Our findings are inconclusive as to the possible effect of metformin on the prognosis of endometrioid EC in women with T2D. However, use of metformin may reduce mortality from other causes.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Arima R., Hautakoski A., Marttila M., Arffman M., Sund R., Ilanne-Parikka P., Kangaskokko J., Hinkula M., Puistola U., Läärä E.,